Loading clinical trials...
Loading clinical trials...
The study evaluates the efficacy and tolerability of alternating short cycles of high-dose and conventional chemotherapy in combination with rituximab in CD20 positive patients, followed by local radi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nicola Goekbuget
NCT04464200 · Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, and more
NCT06563232 · Pancreatic Neoplasms, Mediastinal Neoplasms, and more
NCT03521986 · Mediastinal Neoplasms, Thoracic Neoplasm, and more
NCT01597778 · Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, and more
NCT02669017 · Non-Hodgkin Lymphoma, Burkitt's Lymphoma, and more
University Hospital, Medical Dept. II
Frankfurt
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions